Twist Bioscience (TWST) Assets Average (2018 - 2026)

Twist Bioscience has disclosed Assets Average across 9 years of filings, most recently posting $657.1 million for Q1 2026.

• In Q1 2026, Assets Average rose 9.14% year-over-year to $657.1 million; the TTM figure through Mar 2026 stood at $657.1 million (up 9.14% YoY), while the FY2025 annual figure was $628.1 million, down 9.67% from the prior year.
• Assets Average advanced to $657.1 million in Q1 2026, from $640.0 million in the prior quarter.
• Over the last five years, Assets Average for TWST reached as high as $1.0 billion in Q2 2022 and fell as low as $602.1 million in Q1 2025.
• The 5-year median for Assets Average is $717.8 million (2024), against an average of $756.5 million.
• Annual changes were most pronounced in 2022 — Assets Average jumped 42.69% — and 2024, when it slipped 21.07%.
• A 5-year view of Assets Average shows it stood at $935.7 million in 2022, then declined by 19.35% to $754.6 million in 2023, then dropped by 18.97% to $611.5 million in 2024, then rose by 4.66% to $640.0 million in 2025, then gained by 2.68% to $657.1 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $657.1 million, $640.0 million, and $642.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.